Attention Deficit/Hyperactivity Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Outpatients who meet the diagnostic criteria of ADHD in DSM-5; 2. 6-16 years old, gender unlimited, weight >= 20kg; 3. Boys' ADHD rs-iv-parent: LNv score is not less than 25 points, girls' scores are not less than 22 points, or the scores of subtypes diagnosed in the first interview are all greater than 12 points. CGI-S score >= 4; IQ is normal (WIS score >= 70). 4. The legal guardian shall sign the informed consent before the test; the subjects over 7 years old shall also sign the informed consent of children.
Exclusion criteria
Exclusion criteria: 1. There are serious internal diseases such as heart, liver, kidney, glaucoma, prostate hypertrophy, endocrine, etc., or neuropsychiatric diseases such as epilepsy, mental retardation, etc.; 2. It was diagnosed as tic disorder, loneliness pedigree disorder and other mental disorders; 3. The researchers think that there are clinically significant abnormalities in auxiliary examination and laboratory examination. 4. Participated in clinical trials of other drugs within 3 months before selection; 5. Be allergic to any component in huizhisu; 6. Receive systematic psychotherapy at the same time; 7. Monoamine oxidase inhibitor (MAOI), antipsychotics, antidepressants and mood stabilizers were used two weeks before admission; 8. Have physical diseases that can significantly enhance sympathetic system activity (such as catecholamine secreting neurotumor), or take drugs that mimic sympathetic activity (such as shuchuanling, inhaled aerosol, pseudopilocarpine) every day. 9. The researchers think that there are other common diseases or drugs being taken may interfere with the safe application of huizhisu; 10. At any stage of the study, psychotropic drugs other than the investigational drugs are required, including health care products [such as melatonin (brain platinum)] that the researchers believe have central nervous system activity. 11. Suspect or have a history of alcohol or drug abuse; 12. Women with definite or suspected pregnancy; 13. The researcher believes that the subject and / or the parents or guardians of the subject are not able to fully understand the study or follow the requirements of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHDRS-IV-Parent: The total score of the Inv scale and the changes before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| ADHDRS-IV-Parent:The difference between the scores of attention deficit subscale and hyperactivity impulse subscale of Inv scale and the scores of CGI-S and CGI-I at the end of the 2nd and 8th week compared with the baseline before treatment; | — |
Countries
China
Contacts
Beijing Anding Hospital Affiliated to Capital Medical University